论文部分内容阅读
目的:观察分析吡柔比星为主联合化疗治疗急性白血病的疗效。方法:从我院急性白血病患者中选取68例并将其随机分为治疗组和对照组,对比两组患者治疗效果。结果:治疗组患者临床治疗总有效率高达88.24%,与对照组患者的70.59%相比,有显著性差异(P<0.05)。结论:在治疗急性白血病临床上吡柔比星为主的联合化疗方法效果显著。
Objective: To observe and analyze the efficacy of pirarubicin combined with chemotherapy in the treatment of acute leukemia. Methods: 68 cases of acute leukemia from our hospital were selected and randomly divided into treatment group and control group, the treatment effect of two groups were compared. Results: The total effective rate of clinical treatment in the treatment group was as high as 88.24%, which was significantly different from that in the control group (70.59%, P <0.05). Conclusion: In the treatment of acute leukemia clinically pirarubicin-based combination chemotherapy has a significant effect.